Skip to main content
Premium Trial:

Request an Annual Quote

Abbott and Celera Receive CE Mark for RT-PCR Hepatitis C Test

NEW YORK, July 22 (GenomeWeb News) - Abbott and Celera Diagnostics have received CE Mark certification for a real-time PCR test for monitoring hepatitis C viral load in patients, allowing the test to be marked in the European Union, the companies announced today.

 

The test, called the Abbot RealTime HCV assay, has been developed for use on the Abbott m2000 system, an automated instrument that uses real-time PCR technology provided by Applied Biosystems.

 

In June, Abbott and Celera announced CE Mark certification for the Abbot RealTime HIV-1 assay, also developed for use on the m2000 system.

 

Abbott said additional tests are in development for its m2000 system, including tests for detecting hepatitis B, chlamydia, and gonorrhea.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.